KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Elanco Animal Health (ELAN) Operating Expenses (2017 - 2025)

Historic Operating Expenses for Elanco Animal Health (ELAN) over the last 9 years, with Q3 2025 value amounting to $440.0 million.

  • Elanco Animal Health's Operating Expenses fell 658.17% to $440.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 billion, marking a year-over-year decrease of 3968.33%. This contributed to the annual value of $4.0 billion for FY2024, which is 2959.73% down from last year.
  • Elanco Animal Health's Operating Expenses amounted to $440.0 million in Q3 2025, which was down 658.17% from $492.0 million recorded in Q2 2025.
  • Over the past 5 years, Elanco Animal Health's Operating Expenses peaked at $2.2 billion during Q3 2023, and registered a low of $435.0 million during Q1 2025.
  • For the 5-year period, Elanco Animal Health's Operating Expenses averaged around $1.1 billion, with its median value being $1.2 billion (2022).
  • Its Operating Expenses has fluctuated over the past 5 years, first surged by 12850.68% in 2021, then plummeted by 7824.48% in 2024.
  • Over the past 5 years, Elanco Animal Health's Operating Expenses (Quarter) stood at $1.2 billion in 2021, then dropped by 13.18% to $1.1 billion in 2022, then rose by 8.19% to $1.2 billion in 2023, then fell by 7.83% to $1.1 billion in 2024, then plummeted by 58.92% to $440.0 million in 2025.
  • Its Operating Expenses was $440.0 million in Q3 2025, compared to $492.0 million in Q2 2025 and $435.0 million in Q1 2025.